🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To Evaluate the Pharmacodynamic Equivalence of Albuterol Sulfate Inhalation...
Status
Completed
Location
SPARC Site 02
Start Date
2018-09-22
Trial ID
NCT03528577
This study is designed to evaluate the repeat-dose safety and effectiveness...
Status
Completed
Location
Little Rock Allergy and Asthma
Start Date
2006-06-10
Trial ID
NCT00308685
This study was designed to assess the bioequivalence between the test produ...
Status
Completed
Location
Tamshui Mackay Memorial Hospital
Start Date
2021-03-19
Trial ID
NCT04803734
The purpose of this study is to help determine the best dose of inhaled alb...
Status
Completed
Location
Doernbecher Neonatal Care Center at Oregon Health & Science University
Start Date
2013-10-24
Trial ID
NCT02447250
Treatments Being Tested
Exposure to secondhand tobacco smoke (SHS) is associated with diverse healt...
Status
Active Not Recruiting
Location
VA Medical Center
Start Date
2016-06-06
Trial ID
NCT02797275
The primary objective of this study is to evaluate the efficacy of a single...
Status
Completed
Location
Teva Investigational Site 10557
Start Date
2013-03
Trial ID
NCT01791972
Treatments Being Tested
The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Status
Completed
Location
Advanced Respiratory and Sleep Medicine, PLLC
Start Date
2016-12-27
Trial ID
NCT03480997
Treatments Being Tested
This study was designed to examine the effectiveness of a breath-operated a...
Status
Completed
Location
National Jewish Medical and Research Ceter
Start Date
2003-03-31
Trial ID
NCT00054964
Treatments Being Tested
The study is to evaluate the chronic-dose efficacy and the safety of Albute...
Status
Completed
Location
Teva Investigational Site 12496
Start Date
2014-05
Trial ID
NCT02126839
Treatments Being Tested
This is a prospective, open-label, multicenter Phase 3 study evaluating the...
Status
Completed
Location
Teva Investigational Site 10620
Start Date
2013-05
Trial ID
NCT01857323
Treatments Being Tested